Rockingstone Advisors’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.53M Buy
6,361
+1
+0% +$437 1.02% 40
2026
Q1
$2.93M Buy
6,360
+85
+1% +$43K 1.35% 32
2025
Q4
$3.55M Buy
6,275
+248
+4% +$132K 1.62% 24
2025
Q3
$2.7M Sell
6,027
-30
-0.5% -$14.4K 1.33% 32
2025
Q2
$3.29M Sell
6,057
-2,101
-26% -$1.1M 1.73% 21
2025
Q1
$4.04M Sell
8,158
-345
-4% -$191K 1.82% 18
2024
Q4
$4.44M Sell
8,503
-245
-3% -$128K 1.96% 12
2024
Q3
$4.3M Hold
8,748
2.11% 13
2024
Q2
$3.89M Buy
8,748
+41
+0.5% +$16.3K 2% 15
2024
Q1
$3.47M Sell
8,707
-396
-4% -$150K 1.79% 18
2023
Q4
$3.07M Buy
9,103
+592
+7% +$176K 1.72% 19
2023
Q3
$2.49M Buy
8,511
+62
+0.7% +$19.4K 1.38% 22
2023
Q2
$2.89M Buy
8,449
+81
+1% +$24.5K 1.63% 18
2023
Q1
$2.14M Buy
8,368
+434
+5% +$107K 1.3% 25
2022
Q4
$2.11M Buy
+7,934
New +$1.93M 1.57% 20

Other funds holding ISRG

Rockingstone Advisors's ISRG Position: Q2 2026 in Review

Rockingstone Advisors increased its Intuitive Surgical (ISRG) stake by 0.02% in Q2 2026, buying an estimated $437 and bringing the position to 6,361 shares worth $2.53M. The position accounts for 1.02% of the portfolio, ranked #40.

Rockingstone Advisors first reported a position in ISRG in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.44M in Q4 2024. 955 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Rockingstone Advisors held 6,361 shares of Intuitive Surgical worth $2.53M as of Q2 2026.
  • Rockingstone Advisors bought 1 Intuitive Surgical share in Q2 2026, an estimated $437.
  • Intuitive Surgical made up 1.02% of Rockingstone Advisors's portfolio in Q2 2026, its #40 holding.
  • Rockingstone Advisors first reported a position in Intuitive Surgical in Q4 2022 and has held it in 15 quarters since.
  • Rockingstone Advisors's Intuitive Surgical position peaked at $4.44M in Q4 2024.
  • 955 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Rockingstone Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.